Paula Greter: Access and Innovation in Hemophilia through ERAH2026
Paula Greter, Commercial Strategy and Market Access Director at Roche Brazil, shared a post on LinkedIn:
”Participating in ERAH2026 truly reinforced what drives me at Roche Farma Brasil: our purpose to transform science into hope and meaningful quality of life for families.
This is an unyielding pursuit of solutions that challenge the impossible.
In our long-term journey with the community, hemophilia remains a core priority, keeping us dedicated to securing two essential pillars: access and innovation.
To drive the future forward , we continually invest in developing next-generation approaches.
Alongside this, we take great pride in our humanitarian aid program in partnership with the WFH, bringing access to communities in over 30 countries.
Our commitment is continuous: ensuring that these patients’ lives keep moving forward, always.
Let’s keep this momentum alive.”
Stay updated with Hemostasis Today.
-
Jul 13, 2026, 23:39Yaariv Khaykin: Whole-Person Care Can Strengthen Stroke Prevention in Patients With Atrial Fibrillation
-
Jul 13, 2026, 22:33ESOC 2026 recordings are now available on eSTEP – European Stroke Organisation
-
Jul 13, 2026, 20:17Julia R. Coleman: Fantastic First Day at ISTH 2026
-
Jul 13, 2026, 20:11Ruah Alyamany: Combination Therapy Improves Quality of Life in ITP
-
Jul 13, 2026, 19:47Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026
-
Jul 13, 2026, 19:37Sara Zalghout: Connecting With Colleagues From All Over the World at ISTH 2026
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026